Abstract:Aim: To assess the levels of matrix metalloproteinases (MMP), vascular endothelial growth factor (VEGF), and miRNA-34a expression in patients with ischemic heart disease (IHD) and obstructive and nonobstructive coronary artery (CA) disease. Material and methods: This cross-sectional observational study included 64 patients with IHD (diagnosis verified by coronary angiography or multislice computed tomography coronary angiography), of which 33 (51.6%) were men aged 64.9±8.1 years. 20 patients had nonobstructive CA disease (stenosis <50%), and 44 had hemodynamically significant stenoses. The control group consisted of 30 healthy volunteers. MMP-1, -9, -13, and -14, miRNA-34a, and VEGF were measured in all patients. Results: The concentration of MMP-1 was significantly higher in patients with ischemia and nonobstructive CA disease (INOCAD) (p=0.016), and the concentration of MMP-9 was the highest in the group with obstructive CA disease (p<0.001). The concentrations of MMP-13 and MMP-14 did not differ significantly between the groups. The highest VEGF concentrations were observed in the INOCAD group (p<0.001). The expression of miRNA-34a significantly differed between the IHD groups with different types of CA disease and controls (p <0.001). Patients with hemodynamically significant stenosis showed moderate relationships between the concentrations of MMP-14 and VEGF (ρ=0.418; p=0.024), as well as between VEGF and miRNA-34a (ρ=0.425; p=0.022). Patients with INOCAD had a significant negative correlation between the concentrations of MMP-13 and VEGF (ρ= -0.659; p=0.003). Correlation analysis showed in all IHD patients a moderate relationship of the concentrations of MMP-1 and MMP-14 with VEGF (ρ=0.449; p=0.002 and p=0.341; p=0.019, respectively). According to ROC analysis, a MMP-9 concentration above 4.83 ng/ml can be a predictor for the presence of hemodynamically significant CA obstruction in IHD patients; a VEGF concentration higher than 27.23 pg/ml suggests the absence of hemodynamically significant CA stenosis. Conclusion: IHD patients with INOCAD had the greatest increase in MMP-1, whereas patients with obstructive CA disease had the highest level of MMP-9. According to our data, concentrations of MMP-9 and VEGF can be used to predict the degree of CA obstruction. The expression of miRNA-34a was significantly higher in IHD patients with INOCAD and CA obstruction than in the control group, which suggested a miRNA-34a contribution to the development and progression of coronary atherosclerosis. In the future, it may be possible to use this miRNA as a diagnostic marker for IHD.

Relationship between Myocardial Collateral Vessel Formation and the Levels of Hypoxia-Inducible Factor 1-alpha and Vascular Endothelial Growth Factor A and Its Clinical Significance

The preservation effect of coronary collateral circulation on left ventricular function in chronic total occlusion and its association with the expression of vascular endothelial growth factor A.

Relationship Between Serum Thymosin Β4 Levels and Coronary Collateral Development

Plasma Hyaluronan and Collateral Development in Patients with Coronary Artery Disease

Differential Expression of Vascular Endothelial Growth Factor-A165 Isoforms Between Intracranial Atherosclerosis and Moyamoya Disease.

Relationship between coronary collateral circulation and myocardial viability in patients with chronic total occlusion of coronary artery

Serum Erythropoietin: a Useful Biomarker for Coronary Collateral Development and Potential Target for Therapeutic Angiogenesis among the Patients with Coronary Chronic Total Occlusion.

Analysis of the influencing factors and clinical significance of coronary collateral circulation in patients with chronic total occluded coronary artery disease

Relationship between thrombospondin-1, endostatin, angiopoietin-2, and coronary collateral development in patients with chronic total occlusion.

Association between hibernating myocardium and collateral circulation in patients with coronary chronic total occlusion

Value of myocardial regional perfusion on long-term function in collateral-dependent myocardium.

Plasma Catestatin: A Useful Biomarker for Coronary Collateral Development with Chronic Myocardial Ischemia.

Relationship of myocardial hibernation, scar, and angiographic collateral flow in ischemic cardiomyopathy with coronary chronic total occlusion

Effects of collateral circulation on ventricular function of patients with ST-segment-elevation ;myocardial infarction treated with primary coronary intervention

High-Risk Morphological and Physiological Coronary Disease Attributes As Outcome Markers after Medical Treatment and Revascularization.

Retracted: the Correlation Between Angiogenesis and Abnormal Expression of SERCA2a, Phospholamban and the Endothelin Pathway in Heart Failure, and Improvement by Puerarin

Assessment of the Level of Matrix Metalloproteinases, VEGF and MicroRNA-34a in Patients With Non-obstructive and Obstructive Lesions of the Coronary Arteries

[Value of Evaluating the Coronary Collateral Circulation by Transluminal Attenuation Gradient in Patients with Chronic Total Occlusion and Related Influencing Factors].

The relationship between mean platelet volume lymphocyte ratio and collateral circulation in patients with chronic total coronary occlusion

[Association Between Collateral Circulation and Myocardial Viability Evaluated by Cardiac Magnetic Resonance Imaging in Patients with Coronary Artery Chronic Total Occlusion].

Myocardial Perfusion in Patients with Total Occlusion of a Single Coronary Artery with and Without Collateral Circulation